UPDATE : Wednesday, March 21, 2018
Weak competitiveness hinders biomedicine export to China by Nam Doo-hyun 2017-08-08 14:04
‘Biomedicine is 1 of 6 areas Korea, US leaders should tackle’ by Nam Doo-hyun 2017-08-07 17:08
Medipost’s stem-cell therapy hits record-high sales by Constance Williams 2017-08-04 11:25
Celltrion’s biosimilar takes 30% of Europe market share by Constance Williams 2017-08-01 16:31
5 universities publish most papers in prestigious bio journals by Nam Doo-hyun 2017-08-01 16:18
Medipost hits record sales in Q2 by Marian Chu 2017-08-01 10:00
Celltrion applies for FDA approval of new anticancer biosimilar by Constance Williams 2017-07-31 15:04
Samsung Bioepis, Merck launches biosimilar in US by Marian Chu 2017-07-25 11:27
Nature Cell to unveil stem cell drug for Alzheimer's disease by Constance Williams 2017-07-20 16:41
Sillajen wins approval to start clinical trial in China by Marian Chu 2017-07-20 13:43
‘Stem cell therapy’s problem? No hit item yet’ by Nam Doo-hyun 2017-07-19 18:16
Smaller firms lead domestic stem cell market by Nam Doo-hyun 2017-07-05 13:49
Janssen director points out flaws in Korean quality systems by Constance Williams 2017-06-30 17:09
David and Goliath; how Korean pharmaceuticals should compete with multinational giants by Marian Chu 2017-06-29 09:44
Korean, US firms tie up to bring in Alzheimer treatment by Constance Williams 2017-06-28 17:51
Medytox’s overseas exchange program helps global advances by Constance Williams 2017-06-28 16:43
‘Global Bio Conference 2017’ opens for 3-day run at COEX by Marian Chu 2017-06-28 16:30
KISTI present ways to sharpen competitiveness of precision medicine by Nam Doo-hyun 2017-06-23 13:35
‘Korea needs to develop biomarkers for personalized medical services’ by Nam Doo-hyun 2017-06-22 13:24
'Bio ventures are for developing new drugs, not making cosmetics' by Nam Doo-hyun 2017-06-19 14:47
Back to Top